Eli Lilly (Singapore)

249 papers and 18.7k indexed citations i.

About

In recent decades, authors affiliated with Eli Lilly (Singapore) have published 249 papers, which have received a total of 18.7k indexed citations. Scholars at this organization have produced 66 papers in Molecular Biology, 40 papers in Psychiatry and Mental health and 35 papers in Endocrinology, Diabetes and Metabolism on the topics of Bipolar Disorder and Treatment (23 papers), Alzheimer's disease research and treatments (20 papers) and Diabetes Management and Research (17 papers). Their work is cited by papers focused on Molecular Biology (4.6k citations), Physiology (3.9k citations) and Psychiatry and Mental health (3.8k citations). Authors at Eli Lilly (Singapore) collaborate with scholars in Singapore, United States and United Kingdom and have published in prestigious journals including Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences. Some of Eli Lilly (Singapore)'s most productive authors include Mauricio Tohen, Sergey Shcherbinin, Stephen L. Lowe, Alan Breier and Brian A. Willis.

In The Last Decade

Fields of papers published by authors at Eli Lilly (Singapore)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Eli Lilly (Singapore) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Eli Lilly (Singapore)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Eli Lilly (Singapore). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Eli Lilly (Singapore) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Lilly (Singapore) more than expected).

Rankless by CCL
2025